PKL-IN-1
PKL-IN-1 is a potent inhibitor of pyruvate kinase (PKL) with an IC50 of 0.07 μM. PKL-IN-1 can be used in the study of non-alcoholic fatty liver disease[1].
Product Specifications
UNSPSC
12352005
Target
Pyruvate Kinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pkl-in-1.html
Purity
99.36
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC1=C(O)C=C(C(C(O)=C(O)C(O)=C2)=C2OS3(=O)=O)C3=C1
Molecular Formula
C12H8O8S
Molecular Weight
312.25
References & Citations
[1]Matić J, et al. Sulfone-based human liver pyruvate kinase inhibitors - Design, synthesis and in vitro bioactivity. Eur J Med Chem. 2024;269:116306.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1194145-01 0.05 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details MBS1194145-02 0.05 mg (Baculovirus)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details MBS1194145-03 0.2 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details 
MBS1194145-04 0.2 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details MBS1194145-05 0.5 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details MBS1194145-06 0.05 mg (Mammalian-Cell)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details